皮奥格利塔使用与膀癌之间的关联:系统性审查
Sujatha Baddam1, Amulya Varshini Banka2, Shravani Divity3
1Department of General Medicine, Huntsville Hospital, Huntsville, Alabama, 35801 United States.
Bladder (San Francisco, Calif.)
|February 13, 2025
概括
这次审查检查了皮奥格利塔 (糖尿病药物) 和膀癌 (BC) 风险. 混合的结果显示,一些研究表明存在联系,而另一些研究发现没有显著的关联,表明需要更多的研究.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 膀癌 (BC) 是一个主要的全球健康问题.
- BC发病率受到地理位置,性别和社会经济地位等因素的影响.
研究的目的:
- 系统地审查pioglitazone使用与膀癌 (BC) 风险之间的关联.
- 根据最近的研究,评估一种糖尿病药物pioglitazone是否会增加BC风险.
主要方法:
- 在PubMed,Scopus和Web of Science数据库中进行了全面的文献搜索.
- 包括在2018年1月31日至2024年7月31日期间发表的研究.
- 根据预先定义的标准,在排除了208篇文章后,选择了6项符合条件的研究.
主要成果:
- 其中六项研究中有两项表明,皮奥格利塔使用与膀癌风险增加之间存在潜在关联.
- 四项研究报告说,皮奥格利塔使用与膀癌风险之间没有统计学上显著的相关性.
结论:
- 关于皮奥格利塔和膀癌风险的发现是混合的.
- 需要进一步的研究来澄清这种关系,考虑到治疗持续时间和患者人口统计数据等混因素.
- 必须谨慎解释皮奥格利塔关于膀癌风险的安全性.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Feedback Loops
55.6K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
55.6K


